Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:926-933

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crisby, M.
Right arrow Articles by Nilsson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crisby, M.
Right arrow Articles by Nilsson, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Carotid Artery Disease
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Secondary prevention

(Circulation. 2001;103:926.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques

Implications for Plaque Stabilization

Milita Crisby, MD; Gunilla Nordin-Fredriksson, MD; Prediman K. Shah, MD; Juliana Yano, BS; Jenny Zhu, BS; Jan Nilsson, MD, PhD

From the Department of Neurology, Huddinge University Hospital, Stockholm (M.C.), and Department of Medicine, Malmö University Hospital, Lund University, Malmö (G.N.-F., J.N.), Sweden; and the Atherosclerosis Research Center and the Division of Cardiology, Cedars Sinai Medical Center and UCLA School of Medicine, Los Angeles, Calif (P.K.S., J.Y., J.Z.).

Correspondence to P.K. Shah, MD, Cedars Sinai Medical Center, Room 5347, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail shahp{at}cshs.org; or Milita Crisby, MD, Department of Neurology, Huddinge University Hospital, 141 86 Huddinge, Sweden.

Background—The clinical benefits of lipid lowering with statins are attributed to changes in plaque composition leading to lesion stability, but supporting clinical data from human studies are lacking. Therefore, we investigated the effect of 3 months of pravastatin treatment on composition of human carotid plaques removed during carotid endarterectomy.

Methods and Results—Consecutive patients with symptomatic carotid artery stenosis received 40 mg/d pravastatin (n=11) or no lipid-lowering therapy (n=13; control subjects) for 3 months before scheduled carotid endarterectomy. Carotid plaque composition was assessed with special stains and immunocytochemistry with quantitative image analysis. Plaques from the pravastatin group had less lipid by oil red O staining (8.2±8.4% versus 23.9±21.1% of the plaque area, P<0.05), less oxidized LDL immunoreactivity (13.3±3.6% versus 22.0±6.5%, P<0.001), fewer macrophages (15.0±10.2% versus 25.3±12.5%, P<0.05), fewer T cells (11.2±9.3% versus 24.3±13.4%, P<0.05), less matrix metalloproteinase 2 (MMP-2) immunoreactivity (3.6±3.9% versus 8.4±5.3%, P<0.05), greater tissue inhibitor of metalloproteinase 1 (TIMP-1) immunoreactivity (9.0±6.2% versus 3.1±3.9%, P<0.05), and a higher collagen content by Sirius red staining (12.4±3.1% versus 7.5±3.5%, P<0.005). Cell death by TUNEL staining was reduced in the pravastatin group (17.7±7.8% versus 32.0±12.6%, P<0.05).

Conclusions—Pravastatin decreased lipids, lipid oxidation, inflammation, MMP-2, and cell death and increased TIMP-1 and collagen content in human carotid plaques, confirming its plaque-stabilizing effect in humans.


Key Words: pravastatin • plaque • inflammation




This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Kinlay
Vascular form and function: two mechanisms for cardiovascular prevention
Eur. Heart J., July 2, 2008; 29(14): 1711 - 1713.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Choi, A. Chae, E. Miller, M. Messig, F. Ntanios, A. N. DeMaria, S. E. Nissen, J. L. Witztum, and S. Tsimikas
Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume Observations From the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) Study.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 24 - 32.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Y.-J. Yang, H.-Y. Qian, J. Huang, Y.-J. Geng, R.-L. Gao, K.-F. Dou, G.-S. Yang, J.-J. Li, R. Shen, Z.-X. He, et al.
Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts
Eur. Heart J., June 2, 2008; 29(12): 1578 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
M. Rodriguez-Yanez, J. Agulla, R. Rodriguez-Gonzalez, T. Sobrino, and J. Castillo
Review: Statins and stroke
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 157 - 166.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D. Poldermans, S. E. Hoeks, and H. H. Feringa
Pre-Operative Risk Assessment and Risk Reduction Before Surgery
J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1913 - 1924.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Mannheim, J. Herrmann, D. Versari, M. Gossl, F. B. Meyer, J. P. McConnell, L. O. Lerman, and A. Lerman
Enhanced Expression of Lp-PLA2 and Lysophosphatidylcholine in Symptomatic Carotid Atherosclerotic Plaques
Stroke, May 1, 2008; 39(5): 1448 - 1455.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. J. West, P. J. Nestel, A. C. Kirby, R. Schnabel, D. Sullivan, R. J. Simes, C. Pollicino, E. Lubos, T. F. Munzel, H. D. White, et al.
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study
Eur. Heart J., April 1, 2008; 29(7): 923 - 931.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kinlay, G. G. Schwartz, A. G. Olsson, N. Rifai, M. Szarek, D. D. Waters, P. Libby, P. Ganz, and for the Myocardial Ischemia Reduction with Aggress
Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Kosmidou, J. P. Moore, M. Weber, and C. D. Searles
Statin Treatment and 3' Polyadenylation of eNOS mRNA
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2642 - 2649.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Chaturvedi, T. N. Turan, M. J. Lynn, S. E. Kasner, J. Romano, G. Cotsonis, M. Frankel, M. I. Chimowitz, and For the WASID Study Group
Risk factor status and vascular events in patients with symptomatic intracranial stenosis
Neurology, November 27, 2007; 69(22): 2063 - 2068.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. H.H. Feringa, O. Schouten, S. E. Karagiannis, J. Brugts, A. Elhendy, E. Boersma, R. Vidakovic, M. R.H.M. van Sambeek, P. G. Noordzij, J. J. Bax, et al.
Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery
J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1649 - 1656.
[Abstract] [Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
B. A. Perler
Should Statins Be Given Routinely Before Carotid Endarterectomy?
Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2007; 19(3): 240 - 245.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. H.H. Feringa, S. E. Karagiannis, M. Chonchol, R. Vidakovic, P. G. Noordzij, A. Elhendy, R. T. van Domburg, G. Welten, O. Schouten, J. J. Bax, et al.
Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1872 - 1879.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Le Manach, G. Godet, P. Coriat, C. Martinon, M. Bertrand, M.-H. Fleron, and B. Riou
The Impact of Postoperative Discontinuation or Continuation of Chronic Statin Therapy on Cardiac Outcome After Major Vascular Surgery
Anesth. Analg., June 1, 2007; 104(6): 1326 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kinlay
Low-Density Lipoprotein-Dependent and -Independent Effects of Cholesterol-Lowering Therapies on C-Reactive Protein: A Meta-Analysis
J. Am. Coll. Cardiol., May 22, 2007; 49(20): 2003 - 2009.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
H. Yanai, H. Yoshida, Y. Tomono, and N. Tada
Atherosclerosis imaging in statin intervention trials
QJM, May 1, 2007; 100(5): 253 - 262.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. M. Davidson and M. R. Duchen
Endothelial Mitochondria: Contributing to Vascular Function and Disease
Circ. Res., April 27, 2007; 100(8): 1128 - 1141.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. E. Deanfield, J. P. Halcox, and T. J. Rabelink
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Circulation, March 13, 2007; 115(10): 1285 - 1295.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Verheye, W. Martinet, M. M. Kockx, M. W.M. Knaapen, K. Salu, J.-P. Timmermans, J. T. Ellis, D. L. Kilpatrick, and G. R.Y. De Meyer
Selective Clearance of Macrophages in Atherosclerotic Plaques by Autophagy
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 706 - 715.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, M. Aikawa, F. J. Miller Jr, E. R. Miller, M. Torzewski, S. R. Lentz, C. Bergmark, D. D. Heistad, P. Libby, and J. L. Witztum
Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Cuccurullo, A. Iezzi, M. L. Fazia, D. De Cesare, A. Di Francesco, R. Muraro, R. Bei, S. Ucchino, F. Spigonardo, F. Chiarelli, et al.
Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2716 - 2723.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Tahara, H. Kai, M. Ishibashi, H. Nakaura, H. Kaida, K. Baba, N. Hayabuchi, and T. Imaizumi
Simvastatin Attenuates Plaque Inflammation: Evaluation by Fluorodeoxyglucose Positron Emission Tomography
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1825 - 1831.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Tawakol, R. Q. Migrino, G. G. Bashian, S. Bedri, D. Vermylen, R. C. Cury, D. Yates, G. M. LaMuraglia, K. Furie, S. Houser, et al.
In Vivo 18 F-Fluorodeoxyglucose Positron Emission Tomography Imaging Provides a Noninvasive Measure of Carotid Plaque Inflammation in Patients
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1818 - 1824.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. D. Waters, J. C. LaRosa, P. Barter, J.-C. Fruchart, A. M. Gotto Jr, R. Carter, A. Breazna, J. J.P. Kastelein, and S. M. Grundy
Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1793 - 1799.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
N. N. Boushra and M. Muntazar
Review article: The role of statins in reducing perioperative cardiac risk: physiologic and clinical perspectives: [Le role des statines dans la reduction du risque cardiaque perioperatoire : perspectives physiologiques et cliniques].
Can J Anesth, November 1, 2006; 53(11): 1126 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Versari, J. Herrmann, M. Gossl, D. Mannheim, K. Sattler, F. B. Meyer, L. O. Lerman, and A. Lerman
Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2132 - 2139.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Aboyans, L. Labrousse, P. Lacroix, J. Guilloux, S. Sekkal, A. Le Guyader, E. Cornu, and M. Laskar
Predictive factors of stroke in patients undergoing coronary bypass grafting: statins are protective.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 300 - 304.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. M. Henson, G. P. Cosgrove, and R. W. Vandivier
State of the Art. Apoptosis and Cell Homeostasis in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, August 1, 2006; 3(6): 512 - 516.
[Full Text] [PDF]


Home page
J. Nutr.Home page
X. Xia, W. Ling, J. Ma, M. Xia, M. Hou, Q. Wang, H. Zhu, and Z. Tang
An Anthocyanin-Rich Extract from Black Rice Enhances Atherosclerotic Plaque Stabilization in Apolipoprotein E-Deficient Mice
J. Nutr., August 1, 2006; 136(8): 2220 - 2225.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. A.N. Verhoeven, F. L. Moll, J. A.F. Koekkoek, A. C. van der Wal, D. P.V. de Kleijn, J. P. P.M. de Vries, J. H. Verheijen, E. Velema, E. Busser, A. Schoneveld, et al.
Statin Treatment Is Not Associated With Consistent Alterations in Inflammatory Status of Carotid Atherosclerotic Plaques: A Retrospective Study in 378 Patients Undergoing Carotid Endarterectomy
Stroke, August 1, 2006; 37(8): 2054 - 2060.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-o Deguchi, M. Aikawa, C.-H. Tung, E. Aikawa, D.-E. Kim, V. Ntziachristos, R. Weissleder, and P. Libby
Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo
Circulation, July 4, 2006; 114(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke, July 1, 2006; 37(7): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Circulation, June 20, 2006; 113(24): e873 - e923.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Morimoto, W. J. Janssen, M. B. Fessler, K. A. McPhillips, V. M. Borges, R. P. Bowler, Y.-Q. Xiao, J. A. Kench, P. M. Henson, and R. W. Vandivier
Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.
J. Immunol., June 15, 2006; 176(12): 7657 - 7665.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Martinet, G. R. Y. De Meyer, J.-P. Timmermans, A. G. Herman, and M. M. Kockx
Macrophages but Not Smooth Muscle Cells Undergo Benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-Fluoromethylketone-Induced Nonapoptotic Cell Death Depending on Receptor-Interacting Protein 1 Expression: Implications for the Stabilization of Macrophage-Rich Atherosclerotic Plaques
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1356 - 1364.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Stroke, June 1, 2006; 37(6): 1583 - 1633.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Tsimikas, J. T. Willerson, and P. M. Ridker
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C19 - C31.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Meisner, D. Walcher, F. Gizard, X. Kapfer, R. Huber, A. Noak, L. Sunder-Plassmann, H. Bach, C. Haug, M. Bachem, et al.
Effect of Rosiglitazone Treatment on Plaque Inflammation and Collagen Content in Nondiabetic Patients: Data From a Randomized Placebo-Controlled Trial
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 845 - 850.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Giri, M. M. McDermott, P. Greenland, J. M. Guralnik, M. H. Criqui, K. Liu, L. Ferrucci, D. Green, J. R. Schneider, and L. Tian
Statin Use and Functional Decline in Patients With and Without Peripheral Arterial Disease
J. Am. Coll. Cardiol., March 7, 2006; 47(5): 998 - 1004.
[Abstract] [Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
S. Chaturvedi
Statins Are Associated With Better Outcomes After Carotid Endarterectomy in Symptomatic Patients
Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2006; 18(1): 79 - 80.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Hofnagel, B. Luechtenborg, H. Eschert, G. Weissen-Plenz, N. J. Severs, and H. Robenek
Pravastatin Inhibits Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) in Watanabe Heritable Hyperlipidemic Rabbits: A New Pleiotropic Effect of Statins
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 604 - 610.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P.G. Sluijter, D. P.V. de Kleijn, and G. Pasterkamp
Vascular remodeling and protease inhibition-bench to bedside
Cardiovasc Res, February 15, 2006; 69(3): 595 - 603.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
S. L. Bledsoe, J. C. Barr, R. T. Fitzgerald, A. T. Brown, F. H. Faas, J. F. Eidt, and M. M. Moursi
Pravastatin and Clopidogrel Combined Inhibit Intimal Hyperplasia in a Rat Carotid Endarterectomy Model
Vascular and Endovascular Surgery, January 1, 2006; 40(1): 49 - 57.
[Abstract] [PDF]


Home page
StrokeHome page
N. Nighoghossian, L. Derex, and P. Douek
The Vulnerable Carotid Artery Plaque: Current Imaging Methods and New Perspectives
Stroke, December 1, 2005; 36(12): 2764 - 2772.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Mezzetti
Pharmacological modulation of plaque instability
Lupus, September 1, 2005; 14(9): 769 - 772.
[Abstract] [PDF]


Home page
StrokeHome page
J. L. Martin-Ventura, L. M. Blanco-Colio, A. Gomez-Hernandez, B. Munoz-Garcia, M. Vega, J. Serrano, L. Ortega, G. Hernandez, J. Tunon, and J. Egido
Intensive Treatment With Atorvastatin Reduces Inflammation in Mononuclear Cells and Human Atherosclerotic Lesions in One Month
Stroke, August 1, 2005; 36(8): 1796 - 1800.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Corti, V. Fuster, Z. A. Fayad, S. G. Worthley, G. Helft, W. F. Chaplin, J. Muntwyler, J. F. Viles-Gonzalez, J. Weinberger, D. A. Smith, et al.
Effects of Aggressive Versus Conventional Lipid-Lowering Therapy by Simvastatin on Human Atherosclerotic Lesions: A Prospective, Randomized, Double-Blind Trial With High-Resolution Magnetic Resonance Imaging
J. Am. Coll. Cardiol., July 5, 2005; 46(1): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Kawasaki, K. Sano, M. Okubo, H. Yokoyama, Y. Ito, I. Murata, K. Tsuchiya, S. Minatoguchi, X. Zhou, H. Fujita, et al.
Volumetric Quantitative Analysis of Tissue Characteristics of Coronary Plaques After Statin Therapy Using Three-Dimensional Integrated Backscatter Intravascular Ultrasound
J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1946 - 1953.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yamakuchi, J. J.M. Greer, S. J. Cameron, K. Matsushita, C. N. Morrell, K. Talbot-Fox, W. M. Baldwin III, D. J. Lefer, and C. J. Lowenstein
HMG-CoA Reductase Inhibitors Inhibit Endothelial Exocytosis and Decrease Myocardial Infarct Size
Circ. Res., June 10, 2005; 96(11): 1185 - 1192.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. K. Hansson
Inflammation, Atherosclerosis, and Coronary Artery Disease
N. Engl. J. Med., April 21, 2005; 352(16): 1685 - 1695.
[Full Text] [PDF]


Home page
CirculationHome page
J. Johnson, K. Carson, H. Williams, S. Karanam, A. Newby, G. Angelini, S. George, and C. Jackson
Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E-Knockout Mouse: Model Characterization and Effects of Pravastatin Treatment
Circulation, March 22, 2005; 111(11): 1422 - 1430.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Wentzel, R. Corti, Z. A. Fayad, P. Wisdom, F. Macaluso, M. O. Winkelman, V. Fuster, and J. J. Badimon
Does shear stress modulate both plaque progression and regression in the thoracic aorta?: Human study using serial magnetic resonance imaging
J. Am. Coll. Cardiol., March 15, 2005; 45(6): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
N. P. Kadoglou, S. S. Daskalopoulou, D. Perrea, and C. D. Liapis
Matrix Metalloproteinases and Diabetic Vascular Complications
Angiology, March 1, 2005; 56(2): 173 - 189.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K. O'Neil-Callahan, G. Katsimaglis, M. R. Tepper, J. Ryan, C. Mosby, J. P.A. Ioannidis, and P. G. Danias
Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: The Statins for Risk Reduction in Surgery (StaRRS) study
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 336 - 342.
[Abstract] [Full Text] [PDF]